AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Transgene

Regulatory Filings Jan 4, 2024

1715_rns_2024-01-04_b1728bf6-1257-4cc2-b9d9-65762c7bccd3.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2023

Strasbourg, January 4, 2024 – 05:45 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2023, the following resources were managed through the liquidity account:

  • 303,861 shares
  • € 125,121.00

In the second half of 2023, a total of:

Purchases 157,564
shares
€ 249,580 651 market transactions
Sales 133,103
shares
€ 219,772 613
market transactions

It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:

Cash balance of the liquidity contract: € 500,000.00

At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:

  • 164,183 shares
  • € 246,158.00

Contacts

Transgene:

Arnaud DUBARRY CFO +33 (0)3 88 27 91 00 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.